Holen Sie sich die Stockscreener-App
12.54
0.08%
0.010
Handel nachbörslich:
12.54
Schlusskurs vom Vortag:
$12.53
Offen:
$12.33
24-Stunden-Volumen:
327.07K
Relative Volume:
0.40
Marktkapitalisierung:
$575.39M
Einnahmen:
$524.73M
Nettoeinkommen (Verlust:
$31.70M
KGV:
18.95
EPS:
0.6617
Netto-Cashflow:
$22.47M
1W Leistung:
+1.46%
1M Leistung:
+11.76%
6M Leistung:
-24.18%
1J Leistung:
+0.48%
1-Tages-Spanne:
$11.48
$12.54
1-Wochen-Bereich:
$11.48
$12.86
52-Wochen-Spanne:
$9.79
$20.36
Core Laboratories Inc Stock (CLB) Company Profile
Firmenname
Core Laboratories Inc
Sektor
Telefon
713-328-2673
Adresse
6316 WINDFERN ROAD, HOUSTON
Compare CLB vs SLB, BKR, FTI, HAL, TS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLB
Core Laboratories Inc
|
12.54 | 563.92M | 524.73M | 31.70M | 22.47M | 0.6617 |
SLB
Slb Ltd
|
57.51 | 79.47B | 35.91B | 3.38B | 4.41B | 2.2806 |
BKR
Baker Hughes Company
|
63.50 | 62.32B | 27.89B | 3.15B | 2.29B | 3.1363 |
FTI
Technipfmc Plc
|
79.84 | 30.44B | 10.17B | 1.08B | 1.34B | 2.6138 |
HAL
Halliburton Co
|
37.07 | 29.73B | 22.37B | 1.61B | 1.73B | 1.9091 |
TS
Tenaris Sa Adr
|
56.45 | 26.59B | 12.19B | 2.03B | 1.87B | 3.8072 |
Core Laboratories Inc Stock (CLB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-12 | Hochstufung | Citigroup | Sell → Neutral |
| 2023-06-30 | Herabstufung | Citigroup | Neutral → Sell |
| 2023-04-18 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-01-09 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-10-07 | Hochstufung | Citigroup | Sell → Neutral |
| 2022-09-26 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2022-04-18 | Herabstufung | Piper Sandler | Neutral → Underweight |
| 2021-10-18 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-07-09 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-06-14 | Herabstufung | Citigroup | Neutral → Sell |
| 2020-12-18 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-11-11 | Bestätigt | Cowen | Market Perform |
| 2020-10-13 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2020-09-29 | Hochstufung | ABN Amro | Sell → Hold |
| 2020-07-16 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
| 2020-04-13 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2020-03-09 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2020-03-09 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2020-01-31 | Bestätigt | Cowen | Market Perform |
| 2020-01-30 | Fortgesetzt | Johnson Rice | Buy |
| 2020-01-14 | Eingeleitet | Bernstein | Mkt Perform |
| 2020-01-02 | Herabstufung | Stifel | Buy → Hold |
| 2019-12-31 | Bestätigt | Cowen | Market Perform |
| 2019-07-10 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-02-25 | Hochstufung | Tudor Pickering | Hold → Buy |
| 2018-12-19 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2018-12-11 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2018-11-16 | Hochstufung | Guggenheim | Neutral → Buy |
| 2018-11-01 | Hochstufung | ABN Amro | Sell → Buy |
| 2018-10-29 | Bestätigt | Cowen | Market Perform |
Alle ansehen
Core Laboratories Inc Aktie (CLB) Neueste Nachrichten
Q4 EPS Forecast for Core Laboratories Lifted by Analyst - MarketBeat
John Rogers Buys Core Laboratories Inc (CLB) -- Shares Look 28% Undervalued on GF Value - GuruFocus
101,648 Shares in Core Laboratories Inc. $CLB Purchased by Rice Hall James & Associates LLC - MarketBeat
CLB Q2 2026 Earnings: EPS Beats by 25.1% as Operational Execution Drives ResultsFinancial Summary - vinanet.vn
Renaissance Technologies LLC Sells 132,797 Shares of Core Laboratories Inc. $CLB - MarketBeat
Core Laboratories (CLB) Holds Above $12.40 as Oilfield Services Sector StabilizesTriple Top - vinanet.vn
Disciplined Growth Investors (CLB) reports 6.6% Core Laboratories stake on Schedule 13G/A - Stock Titan
Ariel Investments (CLB) discloses 30.5% Core Laboratories stake in Schedule 13G/A - Stock Titan
Core Laboratories (NYSE:CLB) Stock Rating Upgraded by Johnson Rice - MarketBeat
Core Laboratories Inc. (CLB) stock price, news, quote and history - Yahoo Finance Australia
Core Laboratories Inc. (HJ1.F) stock price, news, quote and history - Yahoo Finance UK
Core Laboratories (CLB) Dips 1.09% to $12.29 as Rangebound Trading PersistsEntry Point Alerts - Vinanet
Core Laboratories N.V. (CLB) stock price, news, quote and history - Yahoo Finance UK
Core Laboratories' (NYSE:CLB) Weak Earnings May Only Reveal A Part Of The Whole Picture - webull.com
Core Laboratories (CLB) Q2 2026 Earnings Call Transcript - The Globe and Mail
Core Laboratories Inc (CLB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Dimensional Fund Advisors LP Increases Stock Position in Core Laboratories Inc. $CLB - MarketBeat
BlackRock (CLB holder) discloses 8.3% beneficial stake in Core Laboratories Inc - Stock Titan
Core Laboratories Inc (CLB) Chairman and CEO Lawrence Bruno Buys 5,000 Shares - GuruFocus
Core Laboratories (NYSE:CLB) CEO Lawrence Bruno Buys 5,000 Shares - MarketBeat
Core Laboratories (NYSE: CLB) CEO purchases 5,000 shares in open-market trade - Stock Titan
Core Laboratories SVP Mark Damian Tattoli Reports August 2026 Share Vesting and Tax-Related Stock Sale - Kalkine Media
Core Laboratories (NYSE:CLB) Rating Increased to Hold at Wall Street Zen - MarketBeat
Core Laboratories Q2 Earnings Call Highlights - MarketBeat
Core Lab Q2 earnings miss analyst estimates By Investing.com - Investing.com Canada
Core Laboratories Inc. (NYSE:CLB) Declares $0.01 Quarterly Dividend - MarketBeat
Core Laboratories (CLB) Q2 Earnings Surpass Estimates - Yahoo Finance Singapore
Core Laboratories Inc reports results for the quarter ended June 30Earnings Summary - tradingview.com
Core Laboratories: Q2 Earnings Snapshot - 10TV
Core Laboratories (NYSE:CLB) Misses Q2 CY2026 Sales Expectations - The Globe and Mail
Press Release: CORE LAB REPORTS SECOND QUARTER 2026 RESULTS - moomoo.com
Core Laboratories (NYSE: CLB) posts Q2 profit, buybacks and Q3 guidance - Stock Titan
Core Laboratories Q2 adj EPS $0.11 beats estimate - scanx.trade
Core Laboratories (CLB) Q2 Earnings Report Preview: What To Look For - Yahoo Finance
CLB|Core Laboratories Inc|Price:11.230|Chg%:-0.440 - TradingKey
Core Laboratories Inc expected to post earnings of 9 cents a shareEarnings Preview - TradingView
Core Laboratories Inc (CLB) Valuation: PE, PB & Fair Value Analysis - TradingKey
Core Laboratories Inc (CLB) Income Statement - TradingKey
Core Laboratories Inc (CLB) Cash Flow - TradingKey
Core Laboratories Inc (CLB) Institutional Confidence - tradingkey.com
Core Laboratories Inc (CLB) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Core Laboratories Inc (CLB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Core Laboratories Inc (CLB) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
CLB|Core Laboratories Inc|Price:12.100|Chg%:+0.750 - tradingkey.com
CLB Q1 2026 Earnings: EPS Misses Estimates Amid Challenging Market ConditionsUpward Estimate Revision - vinanet.vn
Core Laboratories Inc (CLB) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
CLB|Core Laboratories Inc|Price:11.690|Chg%:-0.110 - TradingKey
Core Laboratories (CLB) Shows Resilience With a 2.88% Gain, Approaching Key ResistanceVolume Dry Up - vinanet.vn
What's in Store for Core Laboratories Stock in Q2 Earnings? - Zacks Investment Research
Siemens Healthineers Launches an Industry-leading Menu for Core Lab Capillary Testing on Atellica Analyzers with Claims for 24 Assays - Siemens Healthineers
Core Laboratories (NYSE:CLB) Trading Up 5.9%Here's What Happened - MarketBeat
Finanzdaten der Core Laboratories Inc-Aktie (CLB)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.07%
0.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):